[EGF receptor blockade in immune cells reduces experimental atherosclerosis]

Med Sci (Paris). 2018 Jun-Jul;34(6-7):501-504. doi: 10.1051/medsci/20183406002. Epub 2018 Jul 31.

[Article in French]

Authors

Lynda Zeboudj¹, Pierre-Louis Tharaux¹, Hafid Ait-Oufella²

Affiliations

¹ Inserm U970, centre de recherches cardiovasculaires de Paris, université René Descartes, Paris 5, 75005 Paris, France.
² Inserm U970, centre de recherches cardiovasculaires de Paris, université René Descartes, Paris 5, 75005 Paris, France - Service de réanimation médicale, hôpital Saint-Antoine, AP-HP, université Pierre-et-Marie Curie, Paris 6, 56, rue Leblanc, 75015 Paris, France.

PMID: 30067198
DOI: 10.1051/medsci/20183406002

No abstract available

MeSH terms

Animals
Atherosclerosis / drug therapy
Atherosclerosis / immunology
Atherosclerosis / metabolism*
ErbB Receptors / antagonists & inhibitors*
ErbB Receptors / metabolism
Humans
Leukocytes / metabolism*
Protein Kinase Inhibitors / pharmacology*

Substances

Protein Kinase Inhibitors
ErbB Receptors